We then overexpressed KRAS-G12C mutant (OE-KRAS) or silenced NF1 using siNF1 in the U87 and TBD0220 cells, resulting in the overactivation of RAS and AKT signaling pathways, which mimicked the MES-GBM subtype. This evidence concerns the gene KRAS and glioblastoma.